Investment objective
AIA International Health Care Fund
Key facts
This fund seeks to achieve long-term capital appreciation through investments on a worldwide basis in equity securities of companies that are engaged in the health care and health science industries. A substantial portion of its portfolio will typically be invested in U.S. companies. Through a bottom-up selection process, the team attempts to determine market leaders with superior research, financial controls and marketing capabilities.
Manager of ILP fund
AllianceBernstein (Singapore) Ltd
Annual management fee
1.75% p.a. of Net Asset Value
Source of fund
Cash and SRS
Name of underlying fund
AB SICAV I - International Health Care Portfolio (Luxembourg IHCP)
Manager of underlying fund
AllianceBernstein L.P.
Benchmark
MSCI World Health Care Index
Disclaimer:
Investments are subject to investment risks including the possible loss of the principal amount invested. Past performance of the ILP Funds is not necessarily indicative to its future performance. The performance of the ILP funds are not guaranteed and the value of the units in the ILP funds and the income accruing to the units, if any, may fall or rise. All fund prices shown here are indicative only and are subject to change without prior notice. Performance of the ILP funds are calculated in SGD on a bid to bid basis with any income or dividends reinvested, but excluding such fees and/or charges which may be payable through deduction of premium or cancellation of units. AIA accepts no liability for any loss whatsoever arising directly or indirectly from any use of or reliance on the information provided herein.
